Improving the clinical effectiveness of the treatment of acute inflammatory diseases of the upper respiratory tract in children with the use of silver-based medicines

Introduction. Acute respiratory viral infection (ARVI) is the most common reason for visits to the physician by both children and adults.
The aim of the study was to analyse the features of the course of ARVIs in patients with different immune status, to evaluate the effectiveness of standard therapy for these groups of patients, as well as the use of silver-based medicines in the combination therapy of patients.
Materials and methods. For the period from July to September 2022, 26 children (Group 1) without immunodeficiency conditions and 26 immunocompromised children (Group 2) were identified, all of them had symptoms of acute respiratory viral infections. In Group 1, 69.2% of children (n = 18) were classified as frequently ill children with ARVI rate of more than 8 times per year, 38.4% (n = 10) had allergic rhinitis, 7.7% (n = 2) had a concomitant bronchial asthma. In Group 2, the distribution of underlying immunocompromised disease was as follows: primary immunodeficiency – 7.7% (n = 2), Hurler syndrome after bone marrow transplantation – 11.5% (n = 3), acute lymphoblastic leukemia during specific therapy – 26.9% (n = 7), with graft versus host disease – 30.7% (n = 8) and currently in remission – 23% (n = 6). Among patients in this Group, only 7.7% of children (n = 2) had a history of allergic rhinitis.
Results. The criterion for recovery in Group 1 was reversal of all clinical symptoms, in Group 2 – clinical improvement, normalization or significant decrease in C-reactive protein levels, improvement of paranasal sinuses pneumatization.
Conclusion. During ARVI, post-viral rhinosinusitis often occurs, the ability of the mucosa to regenerate becomes disturbed, which makes it more vulnerable to adhesion of viruses, bacteria, and fungi. In this case, especially effective is the intranasal use of a silver-based medicine to form a protective protein film on the injured mucosa. The use of silver-based medicines in the combination therapy of patients with inflammatory pathologies of the nose, nasopharynx and paranasal sinuses can greatly increase the effectiveness of treatment, while shortening the duration of therapy and being safe.

1. Kryukov A.I., Turovskii A.B., Kolbanova I.G. et al. Guidelines for the acute respiratory viral infection treatment. RMJ. 2019;(8-1):46–50. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Osnovnye_principy_lecheniya_ostroy_respiratornoy_virusnoy_infekcii/.

2. Karpischenko S.A., Tikhomirova E.K. Rhinitis in children of the first years of life. Pediatrics. Consilium Medicum. 2021;(3):224–230. (In Russ.) https://doi.org/10.26442/26586630.2021.3.201147.

3. Kryukov A.I., Kunelskaya N.L., Ivoylov A.Yu., Machulin A.I., Yanovsky V.V. The topical therapy in the treatment of rhinosinusitis in children. RMJ. 2017;(19):1357–1359. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Primenenie_topicheskoy_terapii_v_lechenii_rinosinusita_u_detey

4. Karpishchenko S.A., Alekseenko S.I., Teplova E.O. Diseases of the ENT organs in children (tonsillitis, pharyngitis, sinusitis, otitis). In: Zakharova I.N. (ed.).Pediatrics: pocket recommendations. Moscow: Remedium; 2019, pp. 7–55. (In Russ.)

5. Svistushkin V.M., Morozova S.V., Artamonova P.S. Symptomatic therapy of acute respiratory viral infections with damage to the upper respiratory tract. Consilium Medicum. 2020;22(11):37–42. (In Russ.) https://doi.org/10.26442/20751753.2020.11.200489.

6. Baranov A.A., Namazova-Baranova L.S., Lobzin Yu.V., Uskov A.N., Tatochenko V.K., Bakradze M.D. et al. Federal clinical guidelines for the provision of medical care to children with acute respiratory viral infection (acute nasopharyngitis). Moscow; 2015. 12 p. (In Russ.) Available at: https://minzdrav.gov.ru/ministry/61/5/1/federalnye-klinicheskierekomendatsii-po-okazaniyu-meditsinskoy-pomoschi-detyam-s-orvi.

7. Revyakina V.A., Astafieva N.G., Ilyina N.I., Geppe N.A. PRIMA: Pediatric recommendations for immunomodulatory drugs in outpatient practice (consensus). 2nd ed. Moscow: RG-Press; 2017. 80 p. (In Russ.) Available at: https://pulmodeti.ru/wp-content/uploads/Radar.pdf.

8. Trigubenko R.A., Portenko E.G., Stolyarov D.I. Mucosal immunity in patients with allergic rhinitis caused by the violation of microbiocenosis of the mucous membrane of the nasal cavity. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2018;24(2):81–87. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=35183199.

9. Alekseenko S.I. Interrelation of disorders of mucociliary clearance and morphology of the nasal mucosa in children with various forms of rhinosinusitis. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2021;27(2):4–12. (In Russ.) https://doi.org/10.33848/foliorl23103825-2021-27-2-4-12.

10. Rumyantsev A.G., Maschan A.A., Samochatov E.V. Accompanying therapy and infection control in hematological and oncological diseases. Moscow: Medpraktika; 2009. 530 p. (In Russ.)

11. Eremeeva K.V., Petrova E.I., Svistushkin V.M. Silver proteinate in ENT practice: is the new a well-forgotten old? RMJ. 2015;(23):1381–1383. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Proteinat_serebra_v_LOR-praktike_novoe__eto_horoshozabytoe_staroe.

12. Karpova E.P. Report on the results of a retrospective clinical study of the experience of using nasal forms of silver proteinate in the treatment of acute nasopharyngitis and acute sinusitis in children. Moscow; 2020. (In Russ.)

13. Shakhova E.G. A current view on the problem of rhinitis. RMJ. Medical Review. 2018;(5):3–6. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Sovremennyy_vzglyad_naproblemu_rinita/.

14. Karpishenko S.A., Shumilova N.A. Prospects for the use of silver-based drugs for rhinitis. RMJ. 2018;(10-2):92–96. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Perspektivy_primeneniya_preparatov_na_osnove_serebra_pri_rinitah/.

15. Khrustaleva E.V., Pedder V.V. The possibility of using silver proteinate in complex therapy of rhinosinusitis. RMJ. Medical Review. 2019;(2-2):54–58. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Vozmoghnosti_primeneniya_proteinata_serebra_v_kompleksnoy_terapii_rinosinusitov.

16. Malyavina U.S. Topical drugs for the treatment of inflammatory diseases of the nose and nasopharynx in pediatric practice. RMJ. 2014;(26):1921. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Topicheskie_preparaty_dlya_lecheniya_vospalitelynyh_zabolevaniy_nosa_i_nosoglotki_v_pediatricheskoy_praktike/.

17. Krukov A.I., Ivoylov A.Yu., Kunelskaya V.Ya., Shadrin G.B., Machulin A.I. The experimentally-based rationale for the application of the new methods designed to treat fungal adenoiditis in the children. Vestnik Oto¬Rino¬Laringologii. 2014;(4):49–51. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2014/4/030042-46682014412.

18. Kiselev A.B., Abdulkerimov Kh.T., Terskova N.E., Chaukina V.A. Clinical efficacy of the drug 200 mg silver proteinate in the complex therapy of acute infectious rhinitis in children, which occurred as part of an acute respiratory infection. Rossiiskaya Otorinolaringologiya. 2021;20(4):88–95. (In Russ.) https://doi.org/10.18692/1810-4800-2021-4-88-95.

19. Karpishchenko S.A., Vereshchagina O.E., Teplova E.О. Clinical approach to the selection of topical decongestants in paediatric otolaryngology practice. Meditsinskiy Sovet. 2019;(2):168–172. (In Russ.) https://doi.org/10.21518/2079-701X-2019-2-168-172.

20. Savin E.I., Subbotina T.I., Khadartsev A.A., Khrenov P.A., Chestnova T.V., Buzulukov Yu.P., Antsiferova A.N. Experimental study of antibacterial activity of silver nanoparticles on the model of peritonitis and meningoencephalitis in vivo. Journal of New Medical Technologies. 2014;8(1):1–6. (In Russ.) https://doi.org/10.12737/3865.

21. Kryukov A.I., Tsarapkin G.Yu., Tovmasyan A.S. , Gorovaya E.V., Vershinina E.A. Administration of topical antimicrobial agents in the complex treatment of upper respiratory tract pathology. RMJ. 2020;(5):32–42. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Primenenie_mestnyh_antimikrobnyh_sredstv_v_kompleksnom_lechenii_patologii_verhnih_dyhatelynyh_putey/